Strides Pharma Science is currently trading at Rs. 1535.95 on the BSE, marking a slight increase of 1.30 points or 0.08% from its previous close of Rs. 1534.65.

The stock, which opened at Rs. 1578.50, fluctuated between a high of Rs. 1599.70 and a low of Rs. 1520.70 during the session, with 3471 shares traded so far.

A part of the BSE group 'A' with a face value of Rs. 10, Strides Pharma had its 52-week high at Rs. 1675.25 on October 17, 2024, and its low at Rs. 467.40 on November 6, 2023. Over the past week, the stock's highest and lowest prices were Rs. 1671.10 and Rs. 1518.90 respectively. The company's market capitalization stands at Rs. 14,112.37 crore.

Shareholding is divided with promoters holding 25.84%, institutions at 48.33%, and non-institutional investors at 25.83%.

Strides Pharma Science has received approval to invest up to Rs. 1.61 crore in AMPIN Energy C&I One (AMPIN C&I), aiming to harness solar energy at its Alathur facility in Chennai. This move aligns with the company's goal to increase the use of renewable energy in its operations and meet the legal requirements as a 'captive user' under Indian Electricity Laws.

The investment will go towards establishing captive solar power projects in Tamil Nadu, with completion expected in Q4 FY25. The company’s Board of Directors approved this at their meeting on October 24, 2024.

Strides Pharma, formerly known as Strides Shasun, specializes in developing niche pharmaceutical products, including being one of the largest global producers of soft gelatin capsules.